Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Jun 15, 2026; 18(6): 117851
Published online Jun 15, 2026. doi: 10.4251/wjgo.v18.i6.117851
Published online Jun 15, 2026. doi: 10.4251/wjgo.v18.i6.117851
Table 1 Clinical characteristic of esophageal patients, median (interquartile range)/mean (SD)
| Variables | Whole cohort (n = 206) | Training cohort (n = 144) | Validation cohort (n = 62) | P value |
| Age | 64.1 (7.5) | 64.5 (7.5) | 63.1 (7.4) | 0.218 |
| Gender | 0.570 | |||
| Female | 45 (21.8%) | 33 (22.9%) | 12 (19.4%) | |
| Male | 161 (78.2%) | 111 (77.1%) | 50 (80.6%) | |
| Body mass index | 23.1 (2.65) | 23.1 (2.7) | 23.1 (2.5) | 0.965 |
| Smoking and drinking | 0.267 | |||
| None | 86 (41.7%) | 60 (41.7%) | 26 (41.9%) | |
| Smoking alone | 40 (19.4%) | 29 (20.1%) | 11 (17.7%) | |
| Drinking alone | 13 (6.3%) | 6 (4.2%) | 7 (11.3%) | |
| Both | 67 (32.5%) | 49 (34%) | 18 (29%) | |
| Squamous cell carcinoma level | 1 (0.6, 1.4) | 1 (0.6, 1.4) | 1.1 (0.8, 1.3) | 0.520 |
| Cytokeratin 19 fragment antigen 21-1 level | 1.4 (0.9, 1.8) | 1.4 (0.9, 1.9) | 1.3 (0.8, 1.8) | 0.290 |
| Carcinoembryonic antigen level | 3.4 (2.6, 4.3) | 3.4 (2.6, 4.4) | 3.5 (2.6, 4.2) | 0.924 |
| Carbohydrate antigen 199 | 22.3 (14.9, 29.7) | 22.5 (14.8, 30) | 22.2 (16.8, 27.2) | 0.828 |
| Tumor location | 0.480 | |||
| Upper | 63 (30.6%) | 44 (30.6%) | 19 (30.6%) | |
| Middle | 130 (63.1%) | 89 (61.8%) | 41 (66.1%) | |
| Lower | 13 (6.3%) | 11 (7.6%) | 2 (3.2%) | |
| Tumor length | 3 (2, 4.5) | 3.4 (2, 4.5) | 3 (2, 4) | 0.082 |
| Computed tomography-reported nodal status | 0.407 | |||
| Negative | 148 (71.8%) | 101 (70.1%) | 47 (75.8%) | |
| Positive | 58 (28.2%) | 43 (29.9%) | 15 (24.2%) | |
| Tumor grade | 0.057 | |||
| G1 | 16 (7.8%) | 7 (4.9%) | 9 (14.5%) | |
| G2 | 150 (72.8%) | 109 (75.7%) | 41 (66.1%) | |
| G3 | 40 (19.4%) | 28 (19.4%) | 12 (19.4%) | |
| Depth of tumor invasion | 0.912 | |||
| cT1 | 47 (22.8%) | 33 (22.9%) | 14 (22.6%) | |
| cT2 | 58 (28.2%) | 40 (27.8%) | 18 (29%) | |
| cT3 | 91 (44.2%) | 63 (43.8%) | 28 (45.2%) | |
| cT4 | 10 (4.9%) | 8 (5.6%) | 2 (3.2%) | |
| Node stage | 0.506 | |||
| pN0 | 127 (61.7%) | 89 (61.8%) | 38 (61.3%) | |
| pN1 | 46 (22.3%) | 35 (24.3%) | 11 (17.7%) | |
| pN2 | 19 (9.2%) | 12 (8.3%) | 7 (11.3%) | |
| pN3 | 14 (6.8%) | 8 (5.6%) | 6 (9.7%) | |
| Lymph node metastasis status | 0.944 | |||
| Negative | 127 (61.7%) | 89 (61.8%) | 38 (61.3%) | |
| Positive | 79 (38.3%) | 55 (38.2%) | 24 (38.7%) |
- Citation: Gu RT, Li X, Cheng W, Wang XW, Jin H, Liu T. Machine-learning models integrating preoperative clinical factors and circulating tumor DNA features predict lymph node metastasis in esophageal carcinoma. World J Gastrointest Oncol 2026; 18(6): 117851
- URL: https://www.wjgnet.com/1948-5204/full/v18/i6/117851.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i6.117851